Socrates Heureaux
PSYC325: Biopsychology
Tara Revell
April 1, 2014
Introduction
Here, the topic of interest is Schizophrenia. As it is a mental disability, it is found to be necessary to cope up with this social cause as people suffering to this may produce a threat to the society. Moreover, Schizophrenia is taken as the topic for the research study because individuals with severe mental illness like schizophrenia are at a considerably greater risk of being sufferers of both non-violent and violent crimes (Maniglio; 2009). Furthermore, they themselves can be at a high level of risk as they are unable to differentiate between the real and the unreal.
Schizophrenia: History and Background
Schizophrenia is a psychiatric diagnosis that describes a neuropsychiatric abnormality and a mental disorder. Schizophrenia is a mental disability described by a collapse of general thought process and by poor ability to respond emotionally (concise medical dictionary, 2010). It usually exhibits itself as auditory figment of the imagination, bizarre hallucinations or muddled thinking and speech that is accompanied by momentous social or occupational dysfunctions. The inception of symptoms naturally occurs in early adulthood, with a global life span prevalence of approximately 0.3–0.7% (van, Kapur; 2009). The basis of diagnosis is observed behavior and the reported experiences of the patient.
The disorder is considered usually to affect cognition, but it also very often contributes to inveterate problems with emotions and behavior. People suffering from schizophrenia are prone to have additional conditions that include major anxiety and depression disorders; the lifetime happening of substance abuse is near to 50%. Social troubles, like that of long-term redundancy, hardship and homelessness are common. The average life expectancy of people suffering with schizophrenia is 12 to 15 years lesser than the normal. This is a result
References: Maniglio, R (2009 Mar). "Severe mental illness and criminal victimization: a systematic review". Acta Psychiatrica Scandinavica 119 (3): 180–91. doi:10.1111/j.1600- 0447.2008.01300.x. PMID 19016668. ‘Schizophrenia’. Concise Medical Dictionary. Oxford University Press, 2010. Oxford Reference . Maastricht University Library. Van Os J, Kapur S. ‘Schizophrenia’. Lancet. 2009;374(9690):635–45. doi:10.1016/S0140-6736(09)60995-8. PMID 19700006. Bhugra D (2006). "The global prevalence of schizophrenia". PLoS Medicine 2 (5): 372–373.doi:10.1371/journal.pmed.0020151. Chapman, James. The early symptoms of schizophrenia.British Journal of Psychiatry (London), 112:225-251,1966. Brune, M. (2005). Emotion recognition, ‘theory of mind,’ and social behavior in schizophrenia. Psychiatry Research, 133, 135-147. Judith S. Beck. “Questions and Answers about cognitive therapy”. About cognitive Therapy. Beck Institute for Cognitive Therapy and Research. Melinda Smith and Jeanne Segal, February 2014. Schizophrenia: Signs, Types & Causes.Retrieved from http://www.helpguide.org/mental/schizophrenia_symptom.htm Large, M; Smith, G, Nielssen, O (July 2009). "The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis". Schizophrenia research 112 (1–3): 123–9. doi:10.1016/j.schres.2009.04.004.PMID 19457644. Dr Stefan Leucht, Caroline Corves, Dieter Arbter, Prof Rolf R Engel, Chunbo Li, Prof John M Davis, 3 January 2009. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. The Lancet (Vol. 373, Issue 9657, Pages 31-41 ) DOI: 10.1016/S0140-6736(08)61764-X